CTRI Number |
CTRI/2020/12/029857 [Registered on: 16/12/2020] Trial Registered Prospectively |
Last Modified On: |
15/12/2020 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Pain relief after cesarean operation by nerve blocks |
Scientific Title of Study
|
Comparison of Analgesic Effect between Erector Spinae Plane Block and Transmuscular quadratus lumborum block after Elective Cesarean Section: A Prospective Randomized Double-Blind Study. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Ashok Jadon |
Designation |
Chief Medical Superintendent |
Affiliation |
Tata Motors Hospital |
Address |
Department of Anaesthesia and pain relief service, OT complex, First floor,Tata Motors Hospital, Jamshedpur
Purbi Singhbhum JHARKHAND 831004 India |
Phone |
06576695676 |
Fax |
|
Email |
jadona@rediffmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Ashok Jadon |
Designation |
Chief Medical Superintendent |
Affiliation |
Tata Motors Hospital |
Address |
Department of Anaesthesia and pain relief service,OT complex, First floor, Tata Motors Hospital, Jamshedpur
Purbi Singhbhum JHARKHAND 831004 India |
Phone |
06576695676 |
Fax |
|
Email |
jadona@rediffmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Ashok Jadon |
Designation |
Chief Medical Superintendent |
Affiliation |
Tata Motors Hospital |
Address |
Department of Anaesthesia and pain relief service, OT complex, First floor,Tata Motors Hospital, Jamshedpur
Purbi Singhbhum JHARKHAND 831004 India |
Phone |
06576695676 |
Fax |
|
Email |
jadona@rediffmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Dr Ashok Jadon |
Address |
Department of Anaesthesia and Pain relief, OT complex, First floor,Tata Motors Hospital, Jamshedpur |
Type of Sponsor |
Other [self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Ashok Jadon |
Tata Motors Hospital, Jamshedpur |
Department of Anaesthesia and Pain Relief Service, OT complex First floor Purbi Singhbhum JHARKHAND |
06576695676
jadona@rediffmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Ethical Committee, Tata Motors Hospital |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Erector Spinae Plane Block |
Subject will receive ultrasound-guided bilateral Erector Spinae Plane Block with 20 ml, 0.25% bupivacaine and 4mg dexamethasone each side at thoracic-9 vertebral level through transverse in-plane approach. |
Comparator Agent |
Trans-muscular quadratus lumborum block |
Subject will receive ultrasound-guided bilateral Trans-muscular quadratus lumborum block with 20 ml, 0.25% bupivacaine and 4mg dexamethasone each side at 4th lumbar vertebral level through posterior in-plane approach. |
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Female |
Details |
Full-term pregnant patients scheduled for routine lower segment cesarean section under spinal anaesthesia. |
|
ExclusionCriteria |
Details |
Refusal to participate.Patients with preeclampsia or Eclampsia. Patients having a contraindication to regional anesthesia or allergy to local anaesthetic drugs. Postpartum hemorrhage or surgical complications. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Duration of pain relief |
Request to first rescue analgesia with in 48 hours. |
|
Secondary Outcome
|
Outcome |
TimePoints |
1.Pain scores during rest and on coughing.
2. Amount of Tramadol used in 48 hours.
3. Postoperative nausea, vomiting |
at 2, 4, 8, 12, 24, 48 hours |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
20/12/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response (Others) - Through E-mail on request.
- For how long will this data be available start date provided 28-12-2021 and end date provided 28-12-2023?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
Brief Summary
|
Patients after Caesarean section often suffer from significant postoperative pain. The multimodal analgesia (MMA) regimen is the current standard of care which includes oral analgesic drugs and regional blocks. Trans-muscular Quadratus lumborum block (TQLB) and erector spinae plane blocks (ESPB) are relatively new block which has been used for pain relief in caesarean patients as an adjuvant to MMA. However, comparative studies are lacking. Therefore, we wish to evaluate and compare the analgesic efficacy of TQLB and ESPB in cesarean patients. After acquiring informed consent, we will select 60 pregnant females scheduled for routine lower segment caesarean section (LSCS) under spinal anaesthesia and will randomise them in two equal groups (Group-Q, and Group-E) by the computer-generated random table. Each patient will receive standard anaesthetic care as per hospital protocol. LSCS will be done under spinal anaesthesia. After completion of surgery patients will be positioned in the left lateral decubitus position and will receive either ultrasound-guided ESPB or TQLB with due aseptic precautions and sterile technique. ESPB will be given at the T9 level and using the transverse in-plane approach and TQLB will be given at the L4 level using the posterior in-plane approach. Each patient will receive a bilateral block with 20ml 0.25% bupivacaine mixed with 4 mg dexamethasone at each side. Regular postoperative analgesia will be given with an injection diclophenec 75 mg 12 hourly. Rescue analgesia will be given by patient-controlled analgesia (PCA) pump with tramadol. The pump setting will be, a bolus of 25mg, lock-out time 10 minutes and 4 hour limit of 100mg. The pain assessment will be done at 2,4, 8,12,24,48 hours with a visual analogue score (VAS) of 0 to 10 where 0=no pain and 10=most severe pain during rest and during active coughing. Time to first rescue dose will be considered the duration of analgesia. The primary objective is to compare the duration of analgesia and secondary objectives are a comparison of VAS scores, amount of tramadol used and the complications of the block. Quantitative data will be checked for normality and accordingly t-test or man-Whitney test will be used. Chai-square test or fisher-exact test will be used for qualitative data. The significant difference in the duration of pain relief will be assessed with the log-rank test and Kaplan-Meier graph will be drawn. The statistical analysis will be done with the help of statistical software SPSS version 21. |